Teva- Pharmaceutical Industries Ltd. ADR: Why Investors Shouldn’t Get Rid Of TEVA Stock In 2025
In the last trading session, 10.79 million shares of the Teva- Pharmaceutical Industries Ltd. ADR (NYSE:TEVA) were traded, and its beta was 0.63. Most recently